Toxic epidermal necrolysis. Treatment with pentoxyifylline (original) (raw)

Immunological changes in hydroxyrea-induced collagen disease

Alison Layton

British Journal of Dermatology, 2006

View PDFchevron_right

Drug-induced Hypersensitivity Syndrome in an ANA-negative, anti-dsDNA-negative Systemic Lupus Erythematosus Patient

Paolo Macasaet

Acta Medica Philippina

View PDFchevron_right

Clinica Chimica Acta 328 (2004) 71–82

Yunus Emre YANDI

View PDFchevron_right

Clinica Chimica Acta 332 (2003) 23–30

Yunus Emre YANDI

View PDFchevron_right

Ulcerative lichen planus—like dermatitis associated with hydroxyurea

Miguel Sanchez

Journal of the American Academy of Dermatology, 1991

View PDFchevron_right

Dermatomyositis-like eruption induced by hydroxyurea: a case report

Magdalena Czarnecka-operacz, Maciej Stawny

Acta dermatovenerologica Alpina, Panonica, et Adriatica

View PDFchevron_right

Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual

Jacqueline Junkins-hopkins

International Journal of Dermatology

View PDFchevron_right

Hydroxyurea‑induced superinfected ulcerations: Two case reports and review of the literature

Maria Rotaru

Experimental and Therapeutic Medicine, 2020

View PDFchevron_right

Toxic epidermal necrolysis in two patients with pustular psoriasis

Sarah Rogers

British Journal of Dermatology, 1977

View PDFchevron_right

Hydroxyurea Associated Cutaneous Lesions: A Case Report

Katerina Damevska

Open Access Macedonian Journal of Medical Sciences

View PDFchevron_right

Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation

Ieva Saulite

Arthritis & Rheumatism, 2002

View PDFchevron_right

Role of Hydroxyurea in Psoriasis - A Review

Lubna Khondker

Journal of Bangladesh College of Physicians and Surgeons, 2012

View PDFchevron_right

Adverse reactions of biological therapies in patients with psoriasis

ALEXANDRA LIMBAU

Journal of Mind and Medical Sciences, 2017

View PDFchevron_right

Use of cytotoxic drugs in dermatologic diseases. II

Clement McDonald

Journal of the American Academy of Dermatology, 1985

View PDFchevron_right

Contact lupus erythematosus

M. Deleuran

Contact dermatitis, 2000

View PDFchevron_right

Spontaneous reports of drug-induced erythema multiforme, Stevens - Johnson syndrome and toxic epidermal necrolysis in Denmark 1968-1991

David Gaist

Pharmacoepidemiology and Drug Safety, 1996

View PDFchevron_right

Drug-induced lupus erythematosus

Donatella Schena

Archives of Dermatological Research, 2009

View PDFchevron_right

Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands

andrew franks

Lupus science & medicine, 2017

View PDFchevron_right

Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents

Giampiero Girolomoni

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012

View PDFchevron_right

Erythema Multiforme, Stevens–Johnson Syndrome, and Toxic Epidermal Necrolysis

Katerina Damevska

Springer eBooks, 2021

View PDFchevron_right

Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis

Fukumi Furukawa

Journal of the American Academy of Dermatology, 2000

View PDFchevron_right

Serum sickness–like reaction: Histopathology and case report

Christopher Bunick

Journal of the American Academy of Dermatology, 2011

View PDFchevron_right

Severe cutaneous adverse reactions

Sanjiv Grover

Indian Journal of Dermatology, Venereology, and Leprology, 2011

View PDFchevron_right

Propylthiouracil hypersensitivity: Report of two patients with vasculitis and review of the literature

Erin Boh

Journal of the American Academy of Dermatology, 1999

View PDFchevron_right

A case of toxic epidermal necrolysis: successful treatment with Omalizumab and pulse prednisolone

Ata Yalcin

2016

View PDFchevron_right

Traditional systemic therapy II: retinoids and others (hydroxyurea, thiopurine antimetabolites, mycophenlic acid, sulfasalazine)

Jeffrey Weinberg

Treatment of Psoriasis, 2008

View PDFchevron_right

Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine

Jose Aramendia, Pedro Redondo, V. Vanaclocha

British Journal of Dermatology, 1997

View PDFchevron_right

Adverse reactions of biological therapy for psoriasis

Andreea Dimitriu

2015

View PDFchevron_right

Propylthiouracil-induced lupus-like or vasculitis syndrome

Mehmet Yuruyen

Multidisciplinary respiratory medicine, 2012

View PDFchevron_right

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

S. Halevy

Pharmacogenetics and Genomics, 2008

View PDFchevron_right

Subacute Cutaneous Lupus Erythematosus Induced or Exacerbated by Proton Pump Inhibitors

javier gonzalez

Acta Dermato-Venereologica, 2008

View PDFchevron_right

Toxic epidermal necrolysis like acute cutaneous lupus erythematous or drug induced toxic epidermal necrolysis: case report of a diagnostic dilemma

V. Belgaumkar

International Journal of Research in Dermatology

View PDFchevron_right

Atypical dermatophytosis in a case of systemic lupus erythematosus

Malcolm Pinto

Our Dermatology Online, 2020

View PDFchevron_right

Severe cutaneous adverse reactions to drugs-relevant aspects to diagnosis and treatment-Part I: anaphylaxis and anaphylactoid reactions, erythroderma and the clinical spectrum of Stevens-Johnson syndrome & toxic epidermal necrolysis (Lyell ́s disease)

Paulo Criado

2004

View PDFchevron_right